Details of the Drug

General Information of Drug (ID: DMOWINT)

• Drug Name: Reloxaliase
• Synonyms: ALLN-177

Indication

Disease Entry	ICD 11	Status	REF
Hyperoxaluria	5C51.2	Phase 3	[1]

• Drug Type: Protein
• Cross-matching ID:
  UNII: 48OB405WWC
  DrugBank ID: DB15560
  TTD ID: D1TED8

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Oxalate absorption (Oxalate absor)	TTMDQIJ	NOUNIPROTAC	Replacement	[2]

References

• [1] ClinicalTrials.gov (NCT03847090) Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria (URIROX-2). U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of Allena Pharmaceuticals.